BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1062 related articles for article (PubMed ID: 29547768)

  • 1. Plasticity of myeloid-derived suppressor cells in cancer.
    Tcyganov E; Mastio J; Chen E; Gabrilovich DI
    Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
    Ostrand-Rosenberg S; Fenselau C
    J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.
    Tumino N; Besi F; Martini S; Di Pace AL; Munari E; Quatrini L; Pelosi A; Fiore PF; Fiscon G; Paci P; Scordamaglia F; Covesnon MG; Bogina G; Mingari MC; Moretta L; Vacca P
    Front Immunol; 2021; 12():803014. PubMed ID: 35116033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
    Moses K; Brandau S
    Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization.
    Groth C; Weber R; Lasser S; Özbay FG; Kurzay A; Petrova V; Altevogt P; Utikal J; Umansky V
    Int J Cancer; 2021 Nov; 149(9):1628-1638. PubMed ID: 34224592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
    Karin N
    Front Immunol; 2020; 11():557586. PubMed ID: 33193327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
    Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
    Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
    Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H
    J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CCR5 in directing the mobilization and biological function of CD11b
    Karin N; Razon H
    Cancer Immunol Immunother; 2018 Dec; 67(12):1949-1953. PubMed ID: 30232521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
    Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I
    Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer.
    Ugolini A; Tyurin VA; Tyurina YY; Tcyganov EN; Donthireddy L; Kagan VE; Gabrilovich DI; Veglia F
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32584791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
    Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
    Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.
    Zhou J; Nefedova Y; Lei A; Gabrilovich D
    Semin Immunol; 2018 Feb; 35():19-28. PubMed ID: 29254756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
    Veglia F; Sanseviero E; Gabrilovich DI
    Nat Rev Immunol; 2021 Aug; 21(8):485-498. PubMed ID: 33526920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.
    Grassi G; Vanini V; De Santis F; Romagnoli A; Aiello A; Casetti R; Cimini E; Bordoni V; Notari S; Cuzzi G; Mosti S; Gualano G; Palmieri F; Fraziano M; Goletti D; Agrati C; Sacchi A
    Front Immunol; 2021; 12():594376. PubMed ID: 33981297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions among myeloid regulatory cells in cancer.
    Umansky V; Adema GJ; Baran J; Brandau S; Van Ginderachter JA; Hu X; Jablonska J; Mojsilovic S; Papadaki HA; Pico de Coaña Y; Santegoets KCM; Santibanez JF; Serre K; Si Y; Sieminska I; Velegraki M; Fridlender ZG
    Cancer Immunol Immunother; 2019 Apr; 68(4):645-660. PubMed ID: 30003321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
    Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
    Front Immunol; 2019; 10():1401. PubMed ID: 31275327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Suppressor Cells.
    Gabrilovich DI
    Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diversity of circulating neutrophils in cancer.
    Mishalian I; Granot Z; Fridlender ZG
    Immunobiology; 2017 Jan; 222(1):82-88. PubMed ID: 26874580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
    Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
    J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.